scholarly journals IgE Antibodies from Honeybee Venom Allergic Individuals Recognize Fuc.ALPHA.(1-3)GlcNAc Residue at Innermost Region of N-Glycans from Insects and Plants.

1994 ◽  
Vol 6 (28) ◽  
pp. 155-157
Author(s):  
T. Mori ◽  
W. Shen
Keyword(s):  
Ige Antibodies ◽  
Honeybee Venom ◽  
Glcnac Residue ◽  
Innermost Region

scholarly journals IgE antibodies increase honeybee venom responsiveness and detoxification efficiency of mast cells

Allergy ◽  
2021 ◽  
Author(s):  
Philipp Starkl ◽  
Nicolas Gaudenzio ◽  
Thomas Marichal ◽  
Laurent L. Reber ◽  
Riccardo Sibilano ◽  
...  
Keyword(s):  
Mast Cells ◽  
Ige Antibodies ◽  
Honeybee Venom

IgE Antibodies and FcεRI Are Critical For Acquired Resistance Against Honeybee Venom In Mice

2014 ◽  
Vol 133 (2) ◽  
pp. AB225
Author(s):  
Philipp Starkl ◽  
Thomas Marichal ◽  
Laurent L. Reber ◽  
Janet Kalesnikoff ◽  
Hans C. Oettgen ◽  
...  
Keyword(s):  
Acquired Resistance ◽  
Ige Antibodies ◽  
Honeybee Venom

scholarly journals Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy

2021 ◽  
Vol 38 (5) ◽  
Author(s):  
Tenzin Tender ◽  
Rakesh Ravishankar Rahangdale ◽  
Sridevi Balireddy ◽  
Madhavan Nampoothiri ◽  
K. Krishna Sharma ◽  
...  
Keyword(s):  
Peripheral Neuropathy ◽  
Motor Nerve ◽  
Symptomatic Relief ◽  
Neurological Complication ◽  
Treatment Protocol ◽  
Chemotherapeutic Agents ◽  
Lens Protein ◽  
Active Constituent ◽  
Honeybee Venom ◽  
Eye Lens Protein

Abstract Chemotherapy-induced peripheral neuropathy (CIPN) is the most prevalent neurological complication of cancer treatment which involves sensory and motor nerve dysfunction. Severe CIPN has been reported in around 5% of patients treated with single and up to 38% of patients treated with multiple chemotherapeutic agents. Present medications available for CIPN are the use of opioids, nonsteroidal anti-inflammatory agents, and tricyclic antidepressants, which are only marginally effective in treating neuropathic symptoms. In reality, symptom reappears after these drugs are discontinued. The pathogenesis of CIPN has not been sufficiently recognized and methods for the prevention and treatment of CIPN remain vulnerable to therapeutic problems. It has witnessed that the present medicines available for the disease offer only symptomatic relief for the short term and have severe adverse side effects. There is no standard treatment protocol for preventing, reducing, and treating CIPN. Therefore, there is a need to develop curative therapy that can be used to treat this complication. Melittin is the main pharmacological active constituent of honeybee venom and has therapeutic values including in chemotherapeutic-induced peripheral neuropathy. It has been shown that melittin and whole honey bee venom are effective in treating paclitaxel and oxaliplatin-induced peripheral neuropathy. The use of melittin against peripheral neuropathy caused by chemotherapy has been limited despite having strong therapeutic efficacy against the disease. Melittin mediated haemolysis is the key reason to restrict its use. In our study, it is found that α-Crystallin (an eye lens protein) is capable of inhibiting melittin-induced haemolysis which gives hope of using an appropriate combination of melittin and α-Crystallin in the treatment of CIPN. The review summarizes the efforts made by different research groups to address the concern with melittin in the treatment of chemotherapeutic-induced neuropathy. It also focuses on the possible approaches to overcome melittin-induced haemolysis. Graphic Abstract

Detection and inhibition of IgE antibodies reactive with cross‐reactive carbohydrate determinants in an ELISA for allergen‐specific IgE in horses

2021 ◽  
Author(s):  
Kevin M. Enck ◽  
Kenneth W. Lee ◽  
Brennan H. McKinney ◽  
Karen D. Blankenship ◽  
Cathe Montesano
Keyword(s):  
Specific Ige ◽  
Ige Antibodies

Natural occurrence of IgE antibodies to peptide hormones in man

1989 ◽  
Vol 19 (5) ◽  
pp. 464-465 ◽  
Author(s):  
A. -N. KHALAF ◽  
L. KERP ◽  
B. SCHLIEBS ◽  
M. JÄGLE ◽  
K.-G. PETERSEN
Keyword(s):  
Peptide Hormones ◽  
Natural Occurrence ◽  
Ige Antibodies

In vitro detection of specific IgE antibodies to erythromycin☆☆☆★★★

1995 ◽  
Vol 95 (3) ◽  
pp. 668-671 ◽  
Author(s):  
Cristina Pascual ◽  
Jesus F. Crespo ◽  
Joaquin Quiralte ◽  
Concepcion Lopez ◽  
Gary Wheeler ◽  
...  
Keyword(s):  
Specific Ige ◽  
Ige Antibodies ◽  
Specific Ige Antibodies

scholarly journals Peanut-specific IgE antibodies in asymptomatic Ghanaian children possibly caused by carbohydrate determinant cross-reactivity

2013 ◽  
Vol 132 (3) ◽  
pp. 639-647 ◽  
Author(s):  
Abena S. Amoah ◽  
Benedicta B. Obeng ◽  
Irene A. Larbi ◽  
Serge A. Versteeg ◽  
Yvonne Aryeetey ◽  
...  
Keyword(s):  
Specific Ige ◽  
Cross Reactivity ◽  
Ige Antibodies ◽  
Specific Ige Antibodies
Sign in / Sign up

Export Citation Format

Share Document